Our clinical correlation analysis with multiple public cohorts identified a total of five genes, namely, ADAMTS7, CDH1, DRD5, MGAT5, and TP53, whose mutations were significantly associated with malignant progression and adverse prognosis in PCa. Here, MGAT5 is linked to posterior cortical atrophy.